≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Deaf mutism, not elsewhere classified

EFO MESH Endpoint Browser PheWeb

H8_HL_DEAFMUT

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H91.3
  • Hospital discharge: ICD-9 — 3897
  • Hospital discharge: ICD-8 — 388
  • Cause of death: ICD-10 — H91.3
  • Cause of death: ICD-9 — 3897
  • Cause of death: ICD-8 — 388

2 out of 7 registries used, show all original rules.

208

4. Check minimum number of events

None

208

5. Include endpoints

None

208

6. Filter based on genotype QC (FinnGen only)

185

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H91
Name in latin
Surdomutitas non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2290 1093 1167
Only index persons 1776 903 873
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 43.90 44.20 43.06
Only index persons 35.92 40.27 31.41

-FinnGen-

Key figures

All Female Male
Number of individuals 185 97 88
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 48.12 44.76 51.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
191
Matched controls
1910
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
179.1
221.6
112
15
H91.3
ICD-10 Finland
Deaf mutism, not elsewhere classified
+∞
118.4
101
*
3897A
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]
+∞
64.3
58
*
DFF00
NOMESCO Finland
Pure tone audiometry
17.0
48.5
44
33
N07CA01
ATC
betahistine; oral
9.4
32.4
44
59
Z01.1
ICD-10 Finland
Examination of ears and hearing
7.8
28.6
46
75
Z3229
NOMESCO Finland
Other healthcare associate professional
8.7
27.4
39
55
Z97.4
ICD-10 Finland
Presence of external hearing-aid
65.1
24.8
28
5
38801
ICD-8 Finland
Deaf mutism, Congenita
+∞
23.4
22
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
130.0
22.1
23
*
H93.1
ICD-10 Finland
Tinnitus
25.0
20.2
28
13
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.4
20.1
47
109
R5430
NOMESCO Finland
Interpreter's services
222.1
19.9
20
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
19.5
19.9
30
18
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.9
19.4
33
56
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
78.1
19.1
21
*
DFF15
NOMESCO Finland
Speech audiometry
28.8
17.4
23
9
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
55.5
17.4
20
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
+∞
16.9
16
*
DAX08
NOMESCO Finland
Fitting of hearing aid
46.4
14.4
17
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
57.8
14.0
16
*
DFE00
NOMESCO Finland
Insertion of cochlear implant
+∞
13.7
13
*
38900
ICD-8 Finland
Other deafness, Deafness, both ears
+∞
13.7
13
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
13.7
13
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
150.2
13.6
14
*
UDC00
NOMESCO Finland
Ear microscopy
6.4
13.1
23
40
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
+∞
12.6
12
*
R5120
NOMESCO Finland
Preparation of an aid
19.7
12.3
18
10
DFX00
NOMESCO Finland
Connecting cochlear implant
+∞
11.6
11
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.5
10.9
29
73
38809
ICD-8 Finland
Deaf mutism, Unspecified
+∞
10.5
10
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
9.4
9
*
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
9.4
9
*
38800
ICD-8 Finland
Deaf mutism, Acquisita
+∞
9.4
9
*
3897B
ICD-9 Finland
Deafness, Deaf mutism, not elsewhere classifiable[SURDOMUTITAS]
+∞
9.4
9
*
H91.9
ICD-10 Finland
Hearing loss, unspecified
9.0
9.3
19
23
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
9.2
52
216
R5140
NOMESCO Finland
Monitoring the use of the aid
3.6
9.0
33
105
RK520, ,
NOMESCO Finland
94.0
8.5
9
*
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
+∞
8.4
8
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
46.9
7.8
9
*
RK320, ,
NOMESCO Finland
21.0
7.2
10
5
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.5
7.2
18
43
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.8
6.9
40
167
DC1AD
NOMESCO Finland
Temporalbone CT
23.5
6.7
9
*
H02
ICPC
Hearing complaint
3.2
6.5
27
93
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
72.2
6.5
7
*
SPAT1232
SPAT
Communication with help of interpreter or assistant
72.2
6.5
7
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.9
6.5
33
128
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
+∞
6.3
6
*
Z97.8
ICD-10 Finland
Presence of other specified devices
+∞
6.3
6
*
H81.0
ICD-10 Finland
Ménière disease
10.5
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
50
237
2.50
6.64
2.1
1.7
1359.66
1169.84
nmol/l
0.63
34
193
34
134
2.87
6.47
4.3
4.6
7.38
7.36
ph
0.75
22
97
56
292
2.30
5.96
1.8
1.8
140476645.40
444.30
pmol/l
0.49
42
251
105
707
2.08
5.76
15.3
13.4
1.28
1.27
inr
0.08
84
584
92
608
1.99
5.14
5.0
3.8
40.00
34.30
ng/l
0.21
74
447
9
9
10.42
5.08
1.7
2.3
—
—
—
0
0
77
484
1.99
4.91
2.4
2.0
162.43
210.45
u/l
0.53
77
458
77
489
1.96
4.74
2.4
2.3
—
—
—
0
0
63
385
1.95
4.26
3.5
2.1
3.22
3.06
mg/l
0.17
53
336
33
164
2.22
3.84
2.4
1.7
—
—
—
0
0
22
94
2.51
3.56
11.3
4.2
7.43
7.42
ph
1.06
17
81
106
795
1.75
3.53
7.3
7.3
1.21
1.21
mmol/l
0.18
88
697
18
70
2.73
3.50
6.7
4.8
—
—
—
0
0
35
188
2.06
3.34
2.7
3.4
4.26
4.14
e9/l
0.11
26
161
95
699
1.71
3.32
3.1
2.6
—
—
estimate
—
0
0
144
1191
1.85
3.32
8.6
8.1
76.98
80.78
u/l
0.77
131
1134
66
451
1.71
2.95
1.9
1.7
21.88
21.34
nmol/l
0.07
49
380
95
717
1.65
2.90
12.1
6.3
1.21
1.21
mmol/l
0.40
81
669
27
140
2.08
2.82
2.1
2.0
0.00
0.00
estimate
—
6
25
71
501
1.66
2.79
4.1
3.3
100.49
56.76
mg/l
0.81
40
321
66
461
1.66
2.68
3.6
3.0
—
—
—
0
0
73
524
1.64
2.67
4.1
3.2
6.50
7.43
mmol/l
1.38
57
438
137
1148
1.68
2.66
4.7
4.3
14.92
14.87
pmol/l
0.07
110
1054
22
108
2.17
2.64
6.7
4.0
—
—
—
0
0
7
15
4.80
2.62
2.1
2.1
1.19
1.91
mmol/l
—
7
15
31
174
1.93
2.62
8.2
3.6
7.39
7.39
ph
0.02
14
107
68
488
1.61
2.45
2.8
2.5
54.39
73.22
u/l
0.81
59
458
71
515
1.60
2.45
5.8
6.0
—
—
—
0
0
71
515
1.60
2.45
5.3
3.9
15.99
10.33
mg/mmol
0.53
40
317
157
1379
1.78
2.41
6.1
5.2
1.96
1.95
mu/l
0.02
135
1275
35
214
1.78
2.27
2.4
1.9
—
—
—
0
0
87
672
1.54
2.24
6.0
4.7
35.69
35.40
g/l
0.20
76
642
12
48
2.60
2.23
10.4
2.4
25.07
25.39
mmol/l
0.13
12
48
24
132
1.94
2.16
3.9
5.5
1.33
0.37
%
—
9
41
16
76
2.21
2.09
18.9
4.2
36.94
36.92
°c
0.08
16
76
25
142
1.88
2.05
3.8
5.3
0.56
0.52
%
—
9
49
24
135
1.89
2.02
3.9
5.5
0.00
0.14
%
—
8
42
37
238
1.69
2.01
3.8
2.4
2.43
2.28
g/l
0.71
29
217
87
684
1.50
2.01
2.7
2.1
103.86
97.11
pmol/l
0.52
42
352
60
436
1.55
2.00
5.6
4.1
0.00
0.00
estimate
-0.00
24
143
61
446
1.54
1.97
4.7
4.1
—
—
—
0
0
39
256
1.66
1.97
3.9
2.5
12.85
13.54
umol/l
0.25
33
238
102
833
1.48
1.93
5.5
6.9
9.75
11.46
umol/l
1.51
90
797
87
689
1.48
1.92
4.3
2.9
96.75
117.36
ug/l
0.61
75
639
36
239
1.62
1.74
9.9
7.4
103.83
104.06
mmol/l
0.10
36
239
165
1507
1.70
1.73
26.0
18.5
139.53
139.71
mmol/l
0.37
159
1478
165
1509
1.69
1.70
26.3
18.7
4.00
3.97
mmol/l
0.55
160
1479
22
131
1.77
1.57
4.1
6.0
0.00
0.03
%
—
6
34
7
27
2.65
1.53
4.1
2.9
3.30
4.66
e9/l
—
7
27
29
189
1.63
1.51
1.5
2.9
1.61
1.75
%
0.44
22
175
33
223
1.58
1.49
4.3
2.5
22.37
22.88
%
0.08
25
211
9
38
2.43
1.48
8.7
2.1
7.40
7.42
ph
—
9
38
11
53
2.14
1.41
3.5
3.1
256.00
220.74
mg/l
—
5
23
5
17
2.99
1.36
3.2
2.1
—
—
—
0
0
19
114
1.74
1.34
1.3
1.2
—
—
—
0
0
32
222
1.53
1.30
1.3
1.4
640.00
618.87
titre
—
9
53
21
132
1.66
1.27
2.5
2.6
3.86
6.31
ug/l
0.56
14
117
90
758
1.35
1.26
6.3
6.5
8.71
8.79
%
0.11
84
716
90
759
1.35
1.25
6.4
6.4
0.68
0.67
%
0.06
85
714
90
759
1.35
1.25
6.2
6.3
2.82
2.88
%
0.08
85
715
22
142
1.62
1.21
10.8
9.6
—
—
—
0
0
13
72
1.86
1.18
2.4
2.3
—
—
—
0
0
5
20
2.54
1.16
14.2
2.1
—
—
—
0
0
5
20
2.54
1.16
2.2
1.4
—
—
—
0
0
92
788
1.32
1.11
5.2
3.9
0.00
0.00
estimate
-0.00
26
163
93
798
1.32
1.11
5.2
4.0
0.00
9.67
estimate
0.50
25
168
166
1557
1.51
1.10
14.8
12.1
25.44
25.58
u/l
0.03
155
1525
93
806
1.30
1.01
5.4
4.0
0.00
1.91
estimate
0.50
25
157
15
92
1.68
1.00
1.1
1.3
—
—
—
0
0
7
37
1.93
0.95
5.0
3.0
56.14
59.44
%
—
7
37
9
52
1.77
0.94
9.7
3.6
1.93
1.40
mg/l
—
9
47
95
834
1.28
0.90
6.4
6.3
1.76
1.95
e9/l
0.91
86
736
70
592
1.29
0.89
5.5
3.9
21.74
0.02
estimate
0.48
23
135
29
214
1.42
0.89
1.3
1.2
—
—
—
0
0
8
137
0.57
0.87
1.5
1.4
—
—
—
0
0
151
1411
1.34
0.85
8.2
6.3
40.22
39.63
mmol/mol
0.32
133
1337
168
1596
1.44
0.85
31.9
23.8
258.14
247.95
e9/l
1.12
163
1570
168
1598
1.43
0.83
32.0
24.3
39.98
40.39
%
0.46
162
1586
168
1598
1.43
0.83
31.9
23.9
6.88
6.73
e9/l
0.43
162
1565
168
1598
1.43
0.83
31.8
23.8
4.42
4.48
e12/l
0.79
161
1564
168
1598
1.43
0.83
31.7
23.7
30.28
30.37
pg
0.25
163
1587
168
1598
1.43
0.83
31.7
23.7
91.43
91.36
fl
0.06
163
1588
93
821
1.26
0.82
6.6
6.2
0.61
0.57
e9/l
0.68
82
707
6
32
1.90
0.82
1.5
1.2
9.44
11.33
u/l
—
6
24
168
1599
1.42
0.81
32.2
23.9
132.90
135.02
g/l
1.02
162
1586
93
824
1.25
0.79
6.5
6.2
0.04
0.04
e9/l
0.13
83
709
72
620
1.26
0.78
4.8
3.7
6.22
6.23
ph
0.00
38
351
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
64
544
1.27
0.77
2.9
3.6
2.33
2.35
mmol/l
0.71
52
505
23
308
0.71
0.77
2.4
3.0
0.85
0.86
ug/l
0.01
13
191
5
25
2.03
0.73
12.8
2.3
8.72
8.82
kpa
—
5
25
5
25
2.03
0.73
12.8
2.3
5.10
4.98
kpa
—
5
25
94
840
1.23
0.72
6.8
6.5
0.18
0.19
e9/l
0.52
85
734
10
61
1.67
0.70
1.4
1.5
23.70
28.95
iu/l
—
10
55
53
446
1.26
0.69
4.7
3.2
0.00
0.22
estimate
0.57
20
130
7
42
1.69
0.69
9.4
13.5
—
—
—
0
0
7
42
1.69
0.69
1.1
1.9
58.00
60.60
%
—
7
42
5
27
1.87
0.69
1.2
1.1
—
—
—
0
0
156
1481
1.29
0.65
6.4
5.8
2.61
2.69
mmol/l
0.54
135
1374
99
898
1.21
0.63
8.5
10.4
4.19
4.01
e9/l
0.41
89
785
70
614
1.22
0.63
2.2
2.0
—
—
—
0
0
8
51
1.59
0.61
1.5
1.4
—
—
titre
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
8
54
1.50
0.58
2.3
1.1
—
—
—
0
0
23
178
1.33
0.56
2.9
2.1
256.00
114.65
ug/g
0.74
17
139
9
60
1.52
0.55
1.4
1.2
—
—
—
0
0
9
62
1.47
0.54
2.8
1.8
1.03
1.16
g/l
—
9
62
24
189
1.31
0.53
1.5
1.5
—
—
—
0
0
158
1514
1.25
0.52
21.6
13.2
—
—
—
0
0
13
94
1.41
0.47
1.0
1.2
121.66
160.19
u/ml
—
7
30
150
1438
1.20
0.44
6.1
5.0
6.00
6.00
mmol/l
0.02
126
1323
0
16
0.00
0.41
0.0
1.9
—
41.27
—
0
16
39
337
1.20
0.41
2.0
1.8
1.18
1.38
mg/l
0.21
31
267
76
695
1.16
0.40
15.3
11.0
0.00
0.00
e9/l
0.28
65
571
0
18
0.00
0.40
0.0
2.9
—
41.63
—
0
8
151
1455
1.18
0.38
5.9
5.1
4.55
4.63
mmol/l
0.38
130
1361
11
145
0.74
0.36
1.5
1.6
—
—
—
0
0
23
191
1.23
0.35
1.2
1.2
—
—
—
0
0
28
327
0.83
0.35
2.8
3.0
2.45
2.45
mmol/l
0.00
23
294
150
1448
1.17
0.34
5.9
5.0
1.49
1.47
mmol/l
0.23
129
1343
13
100
1.32
0.34
3.2
6.5
25.72
24.34
mmol/l
0.56
13
94
48
534
0.86
0.34
5.0
3.2
35.55
26.88
e6/l
0.14
35
399
53
480
1.14
0.32
4.3
5.2
2.03
2.24
ug/l
0.12
44
429
41
458
0.87
0.31
5.0
3.1
0.43
0.36
e6/l
0.09
29
323
29
332
0.85
0.30
6.0
4.4
1.02
1.02
kg/l
0.14
17
226
13
103
1.28
0.29
1.9
1.8
—
—
—
0
0
28
245
1.17
0.26
2.4
2.0
29.77
29.62
s
0.06
28
240
5
72
0.69
0.26
2.0
1.7
—
—
—
0
0
11
137
0.79
0.25
1.2
1.5
—
—
—
0
0
11
88
1.27
0.23
3.9
3.7
4.22
4.49
pmol/l
0.55
11
76
5
39
1.29
0.23
3.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
6.97
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
17.3
—
981.70
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
368.14
—
0
7
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
170.52
—
0
13
15
176
0.84
0.21
1.9
4.8
2.82
45.85
ug/l
—
9
153
13
108
1.22
0.20
1.8
1.8
1.01
1.56
g/l
0.93
13
98
151
1476
1.11
0.20
22.2
15.8
24.13
23.34
mg/l
0.10
133
1219
30
271
1.13
0.19
1.3
1.3
3.41
13.88
u/ml
1.17
14
112
35
320
1.11
0.19
1.6
1.4
2.64
2.55
g/l
0.07
19
194
24
268
0.88
0.18
3.9
3.0
1.87
2.46
e6/l
0.29
13
128
17
195
0.86
0.18
3.8
7.8
5.22
5.14
kpa
0.15
17
186
17
195
0.86
0.18
3.8
7.8
12.82
11.90
kpa
0.33
17
188
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
8
72
1.12
0.16
1.0
1.1
—
—
—
0
0
37
343
1.10
0.15
1.5
1.3
1.13
1.83
u/ml
—
6
97
9
80
1.13
0.15
5.8
3.7
1.01
1.02
ratio
—
9
73
62
651
0.93
0.15
2.1
2.0
1.41
1.37
mmol/l
0.13
47
538
11
128
0.85
0.14
2.2
2.5
68.83
67.29
g/l
0.41
11
122
39
365
1.09
0.13
6.5
5.5
—
—
—
0
0
19
172
1.12
0.12
2.2
1.5
—
—
—
0
0
11
95
1.17
0.12
8.5
10.0
25.79
25.50
mmol/l
0.13
11
95
41
388
1.07
0.11
2.1
3.0
336.52
347.44
umol/l
0.21
29
346
57
593
0.94
0.10
5.0
4.0
111.62
43.34
e6/l
0.48
37
412
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
18
165
1.10
0.09
1.3
1.3
—
—
—
0
0
10
113
0.88
0.08
1.1
1.4
—
—
—
0
0
29
306
0.94
0.07
3.4
3.5
1105.95
138.88
ng/l
0.45
22
241
9
88
1.02
0.07
3.2
9.4
17.36
15.33
%
—
9
83
10
89
1.13
0.07
2.0
3.9
—
—
—
0
0
141
1393
1.05
0.07
5.2
4.3
1.28
1.28
mmol/l
0.04
120
1280
23
243
0.94
0.06
2.3
1.7
—
—
—
0
0
53
515
1.04
0.05
5.3
3.8
7.41
7.40
ph
0.90
37
369
22
208
1.07
0.05
2.2
1.5
—
—
—
0
0
42
409
1.03
0.03
1.3
1.4
—
—
—
0
0
15
142
1.06
0.02
1.5
1.6
—
—
—
0
0
59
598
0.98
0.01
4.0
3.3
—
—
—
0
0
35
356
0.98
0.00
4.1
2.6
4.43
4.16
e6/l
0.10
30
323
46
464
0.99
0.00
4.8
6.6
—
—
—
0
0
13
127
1.03
0.00
2.2
2.7
12.60
10.68
g/l
1.07
13
116
15
153
0.98
0.00
1.3
1.4
—
—
—
0
0
11
108
1.02
0.00
1.7
2.3
—
—
—
0
0
11
112
0.98
0.00
3.5
10.6
95.64
93.26
%
1.10
11
112
29
288
1.01
0.00
1.2
1.3
40.98
38.98
iu/ml
0.02
11
110
30
302
0.99
0.00
5.1
3.0
469.54
539.36
mosm/kgh2o
1.40
24
261
19
192
0.99
0.00
3.4
8.0
7.43
7.41
ph
—
9
115
0
9
0.00
0.00
0.0
1.1
—
310.00
—
0
9
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
0.75
—
0
8
9
94
0.96
-0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.60
—
0
5
0
5
0.00
-0.00
0.0
2.4
—
1.19
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
59
1.02
-0.00
1.0
1.2
—
—
—
0
0
6
59
1.02
-0.00
2.3
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_DEAFMUT and mortality.

Females

Parameter HR [95% CI] p-value
H8_HL_DEAFMUT 0.972 [0.76, 1.25] 0.828
Birth year 0.994 [0.99, 1.0] 0.144

During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 364 females with H8_HL_DEAFMUT died.

Males

Parameter HR [95% CI] p-value
H8_HL_DEAFMUT 1.274 [0.94, 1.72] 0.117
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 329 males with H8_HL_DEAFMUT died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_DEAFMUT.

N-year risk Females Males
1 0.062% 0.198%
5 0.475% 1.537%
10 1.164% 3.742%
15 2.581% 6.891%
20 4.467% 12.099%

Relationships between endpoints

↥

Index endpoint: H8_HL_DEAFMUT – Deaf mutism, not elsewhere classified

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data